Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Gapping S&P500 stocks in Tuesday's session ↗
Via Chartmill
Tickers DELL ETN GLW GNRC INTC MU
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Tickers AMBQ BWEN BZFD CNCK CVM ELPW
SAB Biotherapeutics (NASDAQ:SABS) Reports Q1 2026 Miss as Clinical Progress and Extended Cash Runway Through 2028 Take Center Stage ↗
Via Chartmill
Tickers SABS
SFL CORP LTD (NYSE:SFL) Beats Q1 Estimates, Hikes Dividend for 89th Consecutive Quarter ↗
Via Chartmill
Tickers SFL
Sleep Number Corp (NASDAQ:SNBR) Reports Q1 2026 Loss, Revenue Misses Estimates ↗
Via Chartmill
Tickers SNBR
TON Strategy Co. (NASDAQ:TONX) Surges After Q1 Revenue Beat and Staking Yield Milestone ↗
Via Chartmill
Tickers TONX
IceCure Medical (NASDAQ:ICCM) Shares Slide Over 7% Premarket After Q1 Revenue Miss ↗
Via Chartmill
Tickers ICCM
NeuroOne Medical Technologies (NASDAQ:NMTC) Fiscal Q2 Revenue Surges 72% But Misses Estimates, Shares Dip ↗
Via Chartmill
Tickers NMTC
ACCS Misses Q1 Estimates, Subscription Strength Fails to Offset Revenue Decline ↗
Via Chartmill
Tickers ACCS
Netlist (NASDAQ:NLST) Q1 Earnings Beat Sparks 16% Sell-Off ↗
Via Chartmill
Topics Earnings
Tickers NLST
Exposures Financial
XOMA Royalty Corporation (NASDAQ:XOMA) Checks Nearly Every Box in Louis Navellier’s Eight-Rule Growth Stock Screen ↗
Via Chartmill
Tickers XOMA
EOG Resources Inc (NYSE:EOG) is a Compelling Value Pick with Strong Financial Health and Profitability. ↗
Via Chartmill
Tickers EOG
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
Tickers AMD APA COHR HOOD INTC J
Neurocrine Biosciences (NASDAQ:NBIX) Screens as a Peter Lynch-Style GARP Opportunity ↗
Via Chartmill
Tickers NBIX
Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
Via Chartmill
Tickers AMBO BZFD CNCK CREG CVM GTM
Under Armour Inc-CLASS A (NYSE:UAA) Plunges After Q4 Earnings Miss and Weak Fiscal 2027 Guidance ↗
Via Chartmill
Topics Earnings
Tickers UAA
Exposures Financial
Vestis Corp (NYSE:VSTS) Q2 Earnings Beat, Upgrades Full-Year Guidance ↗
Via Chartmill
Topics Earnings
Tickers VSTS
Exposures Financial
Legend Biotech (NASDAQ:LEGN) Q1 2026 Revenue Surges on CARVYKTI Growth, but EPS Falls Short ↗
Via Chartmill
Tickers LEGN
D-Wave Quantum Inc. (NYSE:QBTS) Q1 Revenue Misses but Record Bookings Send Stock Higher ↗
Via Chartmill
Tickers QBTS
Veritone (VERI) Plunges After Q1 Revenue Miss but Reaffirms Full-Year Growth Targets ↗
Via Chartmill
Tickers VERI
Camtek (NASDAQ:CAMT) Q1 2026 Results Inline with Estimates, Shares Dip on Mixed Guidance ↗
Via Chartmill
Tickers CAMT
Tenax Therapeutics (NASDAQ:TENX) Q1 2026 Slightly Beats EPS, Gears Up for Pivotal Phase 3 Data in Q3 ↗
Via Chartmill
Tickers TENX
Janus International Group (NYSE:JBI) Q1 Results: Revenue Beat Overshadowed by EPS Miss ↗
Via Chartmill
Tickers JBI
Arvinas (NASDAQ:ARVN) Q1 2026 Results: First-Ever PROTAC Approval Offsets Revenue Miss ↗
Via Chartmill
Tickers ARVN
ACHV Stock Surges After Achieve Life Sciences Reports Market-Beating Q1 2026 Earnings ↗
Via Chartmill
Tickers ACHV
Harvard Bioscience Inc (NASDAQ:HBIO) Q1 Results Show Revenue Miss Offsets Earnings Beat ↗
Via Chartmill
Tickers HBIO
Olema Pharmaceuticals (NASDAQ:OLMA) Reports Narrower Q1 Loss, Eyes Fall Breast Cancer Data Readout ↗
Via Chartmill
Tickers OLMA
Prelude Therapeutics (NASDAQ:PRLD) Reports Narrower Quarterly Loss, Shares Rise on Cash Runway Extension ↗
Via Chartmill
Tickers PRLD
Acumen Pharmaceuticals (NASDAQ:ABOS) Q1 2026 Loss Narrows as Phase 2 Alzheimer's Trial Readout Looms ↗
Via Chartmill
Tickers ABOS
Broadwind Inc. (NASDAQ:BWEN) Surges After Q1 2026 Earnings Beat ↗
Via Chartmill
Tickers BWEN
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.